Janice Tam
About Janice Tam
Janice Tam is an Associate Scientist at Kite Pharma, specializing in CAR T cell therapy for solid tumors. She has over five years of experience in research, including previous roles as a Senior Research Associate at Kite Pharma and a background in neurobiology and physiology from the University of California, Davis.
Work at Kite Pharma
Janice Tam currently serves as an Associate Scientist at Kite Pharma, a role she has held since 2021. Prior to this position, she worked as a Senior Research Associate II from 2020 to 2022 and as a Senior Research Associate I from 2018 to 2020. Throughout her tenure at Kite Pharma, she has focused on CAR T cell therapy in solid tumors, contributing to advancements in this area of cancer treatment.
Education and Expertise
Janice Tam earned her Bachelor of Science (BS) degree in Neurobiology, Physiology, and Behavior from the University of California, Davis, where she studied from 2012 to 2016. She also completed a minor in Economics during her time at the university. Her educational background provides her with a solid foundation in both biological sciences and economic principles.
Background
Janice Tam has over 5 years of experience in both academia and the biotechnology industry. Her research experience includes studying the role of regulatory T cells (Tregs) in Type-1 diabetes, showcasing her diverse research interests and capabilities. This background has equipped her with valuable skills applicable to her work in CAR T cell therapy.
Achievements
During her career at Kite Pharma, Janice Tam has made significant contributions to the field of CAR T cell therapy, particularly in the context of solid tumors. Her work has been instrumental in advancing therapeutic strategies aimed at improving patient outcomes in cancer treatment. Her research on Tregs in Type-1 diabetes further highlights her commitment to understanding complex biological systems.